Tuaminoheptane

Tuaminoheptane
Clinical data
Trade names	Heptin, Heptadrine, Tuamine
Other names	Tuamine; 2-Aminoheptane; 2-Heptanamine; 1-Methylhexylamine
ATC code	R01AA11 (WHO) ; R01AB08 (WHO) (combinations);
Identifiers
	IUPAC name Heptan-2-amine;
CAS Number	123-82-0 ; 6240-90-0 ((R)-isomer); 44745-29-1 ((S)-isomer);
PubChem CID	5603;
ChemSpider	5401;
UNII	Z0420GYD84;
KEGG	D07371 ;
ChEMBL	ChEMBL123693 ;
CompTox Dashboard (EPA)	DTXSID6048468 ;
ECHA InfoCard	100.004.233
Chemical and physical data
Formula	C7H17N
Molar mass	115.220 g·mol−1
3D model (JSmol)	Interactive image;
Density	0.766 g/mL g/cm3
	SMILES CCCCCC(C)N;
	InChI InChI=1S/C7H17N/c1-3-4-5-6-7(2)8/h7H,3-6,8H2,1-2H3 ; Key:VSRBKQFNFZQRBM-UHFFFAOYSA-N ;

Tuaminoheptane (INNTooltip International Nonproprietary Name, BANTooltip British Approved Name; brand names Heptin, Heptadrine, Tuamine; also known as tuamine and 2-aminoheptane) is a sympathomimetic agent and vasoconstrictor which is used as a nasal decongestant. It has also been used as a stimulant.

Tuaminoheptane has been found to act as a reuptake inhibitor and releasing agent of norepinephrine, which may underlie its decongestant and stimulant effects. It is an alkylamine. The chemical structure of the drug differs from that of other norepinephrine releasing agents, such as the phenethylamines, which, in contrast to tuaminoheptane, have an aromatic ring in their structure.

Tuaminoheptane is on the 2011 list of prohibited substances published by the World Anti-Doping Agency.